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Matrix of death
 
or most normal mammalian cells, survival depends on attachment.
By binding to integrins, many extracellular matrix proteins activate
survival pathways that prevent detachment-induced apoptosis. But
on page 559 Todorovic et al. reveal a matrix molecule that kills instead.
This death matrix protein, CCN1, is selective in its carnage. Endothelial
cells are known to thrive on CCN1, but the group now finds that fibroblasts
are not so lucky. Many fibroblasts that attach and spread on a CCN1 matrix
die, despite activating the FAK–JNK cell survival pathway.
The different outcomes might lie in the combination of integrins and
their coreceptors. Endothelial cells use integrin 
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 to activate FAK, which
turns on multiple survival signals in various cell types. But fibroblasts are also
known to interact with CCN1 via integrin 
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. Antibodies that blocked this
integrin or its syndecan-4 coreceptor prevented apoptosis.
How this integrin activates death is still fuzzy. Bcl family proteins and
F
As CCN1 induces apoptosis in fibroblasts, the fibroblast 
mitochondria gain Bax (green, top) and lose cyto-
chrome c (green, bottom).
 
p53 were necessary, as were caspases-3 and -9. Detachment-induced apoptosis, by contrast, depends on
caspase-8. Caspases-3 and -9 are mediators of stress-induced apoptosis, but the authors do not yet know
what, if any, cellular stress CCN1 might be triggering.
After development, CCN1 is primarily expressed during inflammation and wound healing.
Wounds are sealed by large numbers of fibroblasts that are then removed to prevent scar tissue formation.
With its contrasting outcomes, CCN1 may be both the trigger for this massive death and the support
system for the renewing vasculature. During development, CCN1 might create a sharp boundary between
tissues, as would any other matrix found to be similarly bipolar, by supporting growth of one cell type
while simultaneously killing off those of a neighboring tissue. 
 
Transformed fusions
 
he occasional accidental fusion between somatic cells is probably
harmless to an organism, as the resulting cell generally does not
divide. But viruses have the ability to create proliferative fused
cells, according to Duelli et al. (page 493). The authors wonder whether
viruses might thus contribute to carcinogenesis.
The authors were studying human fibroblasts expressing the E1A
oncogene when they noticed that the cells fused with normal fibroblasts. The
fusogenic activity derived from a contaminating retrovirus, Mason-Pfizer
monkey virus (MPMV), in the oncogenic cell line. Exosome-like infectious
MPMV particles caused fusion between these cells and the normal fibro-
blasts. It is not known how the virus causes fusion, although the authors
show that exosomal tetraspanins are required.
Virus-instigated fusion is not new, but the products of these fusions
were oddly proliferative. The group determined that this ability stemmed
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The fusion (arrows) of normal (blue) and MPMV-con-
taining (green) fibroblasts forms transformed tetraploids.
 
from the presence of one of several oncogenes and the ability of the virus to fuse two rather than many cells.
Fused cells did not proliferate unless one of the partners expressed an oncogene, such as E1A or c-Myc. Mutant
p53 tumor suppressor activity in one fusion partner also led to proliferation of fused cells.
Fusion potentially combines the properties of very different cell types, making the behavior of the re-
sulting hybrid highly unpredictable. Their duplicated centrosomes also make them prone to aneuploidy, which
is a common feature of cancer cells. Indeed, recent studies showed that tetraploid cells with mutations in a tumor
suppressor generated cancerous aneuploid cells (Fujiwara et al. 2005. 
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. 1043–1047).
Whether viruses create proliferative fused cells in an organism is not yet known, but a virus that provides the
machinery for both fusion and deregulated cell cycles might
be especially dangerous. Therapeutic treatments that involve
either viral vector sequences (as in gene therapy) or cell
fusion (as in stem cell treatments) should thus be carefully
examined for potential cancer-causing side effects. 
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